Zentalis Pharmaceuticals Llc (ZNTL NASDAQ) stock market data APIs

$1.2575 0(0%)
as of July 3, 2025
Try our APIs with free plan!

Zentalis Pharmaceuticals Llc Financial Data Overview

Price chart is built with Anychart

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Prev. Close 1.2575
Open 1.2575
High 1.2719
Low 1.25
52 wk Range 1.01-5.44
Market Cap 90 659 K
Shares Outstanding 71 952 K
Revenue 26 865 K
EPS -0.67
Beta 1.614

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Zentalis Pharmaceuticals Llc data using free add-ons & libraries


Get Zentalis Pharmaceuticals Llc Fundamental Data

Zentalis Pharmaceuticals Llc Fundamental data includes:

  • Net Revenue: 26 865 K
  • EBITDA: -199 292 992
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Zentalis Pharmaceuticals Llc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-05-05
  • EPS/Forecast: -0.6069
GET THE PACKAGE

Get Zentalis Pharmaceuticals Llc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Zentalis Pharmaceuticals Llc News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat